https://european-biotechnology.net/wp-content/uploads/2024/11/EB424_Agricouncil_Consilium_tg-scaled-e1732031435528-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-19 16:04:062024-11-19 16:04:06Country alliance calls for EU protein strategy
https://european-biotechnology.net/wp-content/uploads/2024/10/Scotland-1030x618-1.jpg6181030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-19 05:17:342024-11-19 05:17:34ATB Therapeutics raises €54m in Series A financing
https://european-biotechnology.net/wp-content/uploads/2024/11/Exosome-signalling-1030x515-1.jpg5151030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-13 08:47:472024-11-13 08:47:47Pharmahungary Group participates in ambitious EU EVEREST Project
https://european-biotechnology.net/wp-content/uploads/2024/11/Alentis-1030x458-1.jpg4581030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-13 08:00:462024-11-13 08:00:46Alentis Therapeutics raises US$181.4m in Series D financing
https://european-biotechnology.net/wp-content/uploads/2024/11/GeldLSP-1030x782-1.jpg7821030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-12 06:30:482024-11-12 06:30:48Alentis Therapeutics raises US$181.4m in Series D financing
https://european-biotechnology.net/wp-content/uploads/2024/11/MSK.jpg533800Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-11-10 14:20:092024-11-10 14:20:09Harbinger Health to speed up clinical cancer test validation
